A J Levine

3.5k total citations · 1 hit paper
19 papers, 3.0k citations indexed

About

A J Levine is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, A J Levine has authored 19 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in A J Levine's work include Cancer-related Molecular Pathways (13 papers), Virus-based gene therapy research (5 papers) and Epigenetics and DNA Methylation (5 papers). A J Levine is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Virus-based gene therapy research (5 papers) and Epigenetics and DNA Methylation (5 papers). A J Levine collaborates with scholars based in United States, France and Israel. A J Levine's co-authors include Xiangwei Wu, Ingo Georgoff, Juan C. Garro Martínez, Jaimo Ahn, Maureen E. Murphy, Donna L. George, Ronald M. Evans, William H. Hoffman, Jacques Piette and Jean‐Claude Nicolas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and Molecular and Cellular Biology.

In The Last Decade

A J Levine

18 papers receiving 2.9k citations

Hit Papers

p53 and E2F-1 cooperate to mediate apoptosis. 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A J Levine United States 15 2.2k 2.1k 595 399 357 19 3.0k
Dan Michalovitz Israel 9 1.4k 0.6× 1.7k 0.8× 589 1.0× 390 1.0× 358 1.0× 10 2.2k
Barbara Faha United States 15 1.7k 0.8× 1.6k 0.8× 221 0.4× 637 1.6× 335 0.9× 19 2.5k
Brian Elenbaas United States 17 2.8k 1.3× 2.4k 1.2× 524 0.9× 511 1.3× 640 1.8× 26 4.1k
Warren Maltzman United States 12 1.3k 0.6× 1.4k 0.7× 440 0.7× 538 1.3× 278 0.8× 15 2.1k
Robert L. Ludwig United States 18 3.3k 1.5× 2.4k 1.1× 452 0.8× 174 0.4× 693 1.9× 20 4.1k
Aart G. Jochemsen Netherlands 34 2.8k 1.3× 2.0k 0.9× 406 0.7× 391 1.0× 483 1.4× 70 3.7k
P. Renée Yew United States 15 1.9k 0.9× 1.5k 0.7× 140 0.2× 335 0.8× 254 0.7× 23 2.4k
Karen Buchkovich United States 11 1.9k 0.8× 2.2k 1.1× 203 0.3× 1.2k 2.9× 304 0.9× 14 3.5k
Kenneth Fernandes United Kingdom 18 1.6k 0.7× 931 0.4× 240 0.4× 502 1.3× 283 0.8× 26 2.3k
Liang Zhu United States 24 2.0k 0.9× 1.8k 0.9× 141 0.2× 431 1.1× 258 0.7× 46 3.0k

Countries citing papers authored by A J Levine

Since Specialization
Citations

This map shows the geographic impact of A J Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A J Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A J Levine more than expected).

Fields of papers citing papers by A J Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A J Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A J Levine. The network helps show where A J Levine may publish in the future.

Co-authorship network of co-authors of A J Levine

This figure shows the co-authorship network connecting the top 25 collaborators of A J Levine. A scholar is included among the top collaborators of A J Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A J Levine. A J Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Topp, William C., Jennifer Hall, Margery P. F. Marsden, et al.. (2024). In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells. PubMed. 36(11 Pt. 2). 4217–23.
2.
Levine, A J. (2011). Introduction: The Changing Directions of p53 Research. Genes & Cancer. 2(4). 382–384. 16 indexed citations
3.
Ishihara, Kazuki, Kazuaki Tanaka, Kimiko Inoue, et al.. (2006). The Xist RNA Gene Evolved in Eutherians by Pseudogenization of a Protein-Coding Gene. 18 indexed citations
4.
Harris, Sandra, Germán A. Gil, Wenwei Hu, et al.. (2005). Single-Nucleotide Polymorphisms in the p53 Pathway. Cold Spring Harbor Symposia on Quantitative Biology. 70(0). 111–119. 8 indexed citations
5.
Murphy, Maureen E., Jaimo Ahn, William H. Hoffman, et al.. (1999). Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes & Development. 13(19). 2490–2501. 386 indexed citations
7.
Lin, Jiayuh, et al.. (1996). Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities. Molecular and Cellular Biology. 16(4). 21 indexed citations
8.
Maréchal, Vincent, Brian Elenbaas, Jacques Piette, Jean‐Claude Nicolas, & A J Levine. (1994). The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes.. Molecular and Cellular Biology. 14(11). 7414–7420. 266 indexed citations
9.
Quartin, Robin S., Charles N. Cole, James M. Pipas, & A J Levine. (1994). The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. Journal of Virology. 68(3). 1334–1341. 64 indexed citations
10.
Wu, Xiangwei & A J Levine. (1994). p53 and E2F-1 cooperate to mediate apoptosis.. Proceedings of the National Academy of Sciences. 91(9). 3602–3606. 743 indexed citations breakdown →
11.
Levine, A J. (1992). The p53 tumour suppressor gene and product.. PubMed. 12. 59–79. 58 indexed citations
12.
Shaulsky, Gad, et al.. (1991). Nuclear localization is essential for the activity of p53 protein.. PubMed. 6(11). 2055–65. 166 indexed citations
13.
Martínez, Juan C. Garro, Ingo Georgoff, & A J Levine. (1991). Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.. Genes & Development. 5(2). 151–159. 484 indexed citations
14.
Zambetti, Gerard P., Robin S. Quartin, Jean Martínez, et al.. (1991). Regulation of Transformation and the Cell Cycle by p53. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 219–225. 8 indexed citations
15.
Levine, A J, et al.. (1991). p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts.. Genes & Development. 5(12b). 2375–2385. 396 indexed citations
16.
Labow, Mark, et al.. (1991). A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside.. Proceedings of the National Academy of Sciences. 88(12). 5072–5076. 83 indexed citations
17.
Levine, A J. (1989). The p53 tumor suppressor gene and gene product.. PubMed. 20. 221–30. 45 indexed citations
18.
Tan, Tse‐Hua, Julie Wallis, & A J Levine. (1986). Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex. Journal of Virology. 59(3). 574–583. 158 indexed citations
19.
Schutzbank, Ted E. & A J Levine. (1982). Cells transformed by a wide variety of agents express higher abundance levels of some cellular RNA species. Journal of Cellular Biochemistry. 19(3). 259–265. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026